PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.\', \'Carterra, 825 N. 300 W. Ste C309, Salt Lake City, UT 84103, USA.\', \'Center for Human Systems Immunology, Departments of Surgery, Immunology, and Molecular Genetics and Microbiology and Duke Human Vaccine Institute, Duke University, Durham, NC 27701, USA.\', \'Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location AMC, University of Amsterdam, Amsterdam Infection & Immunity Institute, 1105 AZ Amsterdam, Netherlands.\', \'Quadrucept Bio, Ltd., Cambridge CB23 6DW, UK.\', \'Myrio Therapeutics Pty, Ltd., 1 Dalmore Drive, Scoresby, VIC 3179, Australia.\', \'National Resilience, Inc., 13200 NW Nano Ct., Alachua, FL 32615, USA.\', \'Generate Biomedicines, Inc., 26 Landsdowne Street, Cambridge, MA 02139, USA.\', \'Activemotif, Inc., 1914 Palomar Oaks Way, Suite 150, Carlsbad, CA 92008, USA.\', \'Centivax, Inc., 201 Gateway Blvd., Floor 1, South San Francisco, CA 94080, USA.\', \'Twist Bioscience, 681 Gateway Blvd., South San Francisco, CA 94080, USA.\', \'Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, 701 West 168th St., HHSC 1102, New York, NY 10032, USA.\', \'Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital and Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan, Taiwan.\', \'Shanghai Henlius Biotech, Inc., 9/F, Innov Tower, Zone A, no. 1801 Hongmei Road, Xuhui District, Shanghai, China.\', \'Kymab, Ltd., The Bennet Building, Babraham Research Campus, Cambridge CB22 3AT, UK.\', \'Department of Infectious Disease, Imperial College, London SW7 2AZ, UK.\', \'Celltrion, Inc., Department of Research and Development, 23 Academy-ro Yeonsu-gu Incheon, Republic of Korea.\', \'Sanyou Biopharmaceuticals Co., Ltd., no. 188 Xinjunhuan Road, Building 6B-C, 3rd Floor, Minhang District, Shanghai 201114, China.\', \'Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD 20910, USA.\', \'Shanghai Key Laboratory of Medical Epigenetics, International Laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.\', \'AbCipher Biotechnology, 188 Xinjun Ring Road, Building 2, 4th Floor, Minhang District, Shanghai 201114, China.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.\', \'Institute of Cancer Research, Centre for Cancer Drug Discovery, London SM2 5NG, UK.\', \'Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, Baltimore, MD 21201, USA.\', \'HiFiBiO, Inc., 237 Putnam Avenue, Cambridge, MA 02139, USA.\', \'National Resilience, Inc., 2061 Challenger Dr., Alameda, CA 94501, USA.\', \'Department of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1126/science.abh2315
?:hasPublicationType
?:journal
  • Science (New York, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 34554826
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all